PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

▼

Showing posts with label Merck KGaA. Show all posts

Showing posts with label Merck KGaA. Show all posts

Merck KGaA and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab

Merck KGaA, Darmstadt and Pfizer announced the initiation of two Phase III studies of avelumab*, an investigational, fully human anti-PD-L1...

Merck KGaA and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015

Merck KGaA, Darmstadt, Germany and Pfizer announced that six abstracts on studies evaluating the potential role of programmed death-ligan...

View web version

Powered by Blogger.